Effects of radiotherapy on plasma energy metabolites in patients with breast cancer who received neoadjuvant chemotherapy
-
M. Arenas [1] ; S. Fernández Arroyo [2] ; E. Rodríguez Tomàs [2] ; S. Sabater [1] ; Y. Murria [1] ; M. Gascón [1] ; K. Amillano [3] ; M. Melé [3] ; J. Camps [2] ; J. Joven [2]
-
[1] Department of Radiation Oncology, Hospital Universitari Sant Joan de Reus, Institut d’Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus, Spain
-
[2] Unitat de Recerca Biomèdica, Hospital Universitari Sant Joan de Reus, Institut d’Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus, Spain
-
[3] Department of Medical Oncology, Hospital Universitari Sant Joan de Reus, Institut d’Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus, Spain
-
- Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 22, Nº. 7, 2020, págs. 1078-1085
- Idioma: inglés
- Texto completo no disponible (Saber más ...)
-
Resumen
PurposeNeoadjuvant chemotherapy (NACT) is employed in patients with breast cancer (BC) with the aim of reducing tumor burden and improving surgical outcomes. We evaluated the levels of energy metabolites pre- and post-radiotherapy (RT) in breast cancer (BC) patients who previously received NACT and investigated the alterations of these metabolites in relation to the patient achieving a pathologic complete response to NACT.Materials and methodsWe included 37 BC patients who were treated with NACT following surgery and analyzed the con-centrations of energy balance-related metabolites using targeted metabolomics before and one month after the end of RT. The control group was composed of 44 healthy women.ResultsPre-radiotherapy, patients had significant decreases in the plasma levels of 12 metabolites. RT corrected these altera-tions and the improvement was superior in patients with a pathologic complete response.ConclusionOur results highlight the importance of metabolism in the outcomes of patients with BC.
